MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Blood Adv · 2026 · PMC12914417 · PMID 41529224

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

borderline significanceP = .054so close (0.05 < p ≤ 0.1)

After adjusting for covariates age, cycles of chemotherapy to achieve CR, and WBC count, concurrent STM had a prognostic unfavorable effect regarding the clinical outcome of patients with ELN2022 favorable-risk AML with borderline significance (HR, 1.46; P = .054) ( supplemental Figure 6 ; supplemental Table 8 ).

also in 4,352 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.